Literature DB >> 27997912

Analysis of the Indicating Value of Cardiac Troponin I, Tumor Necrosis Factor-α, Interleukin-18, Mir-1 and Mir-146b for Viral Myocarditis among Children.

Dahui Wang1, Taijun Li, Hongjie Cui, Yanming Zhang.   

Abstract

BACKGROUND/AIMS: The primary objective of this study is to evaluate the diagnosis effect of serum protein factors and microRNAs for children suffering from viral myocarditis (VMC).
METHODS: The expression levels of serum cardiac troponin I (cTnI), interleukin-18 (IL-18) and tumor necrosis factor-α (TNF-α) in both VMC and control groups were examined by using the Elisa Kit. The expression levels of miR-1 and miR-146b were measured through RT-PCR. Subsequently, the Receiver Operating Characteristic (ROC) curves were drawn based on the diagnostic results of VMC. Moreover, the Spearman correlation analysis was carried out to unveil the association between the indicator expression levels and the ultrasonic cardiogram results, including the left ventricular fractional shortening (FS) and left ventricular ejection fraction (EF).
RESULTS: It is found that the expression levels between the VMC and control group portrait significant differences with respect to cTnI, IL-18, TNF-α, miR-1 and mIR-146b (P < 0.05). The diagnostic thresholds for cTnI, IL-18, TNF-α were 160.00 ng/L, 2.26 ng/L and 1.14ng/L, respectively. The diagnostic thresholds for miR-1 and miR-146b were 0.75 and 1.27, respectively. Results from the Spearman correlation analysis showed that levels of the miR-1 were negatively correlated with FS and EF, while levels of the cTnI, IL-18, TNF-α and miR-146b were positively correlated with FS and EF.
CONCLUSIONS: The expression levels of the TNF-α, IL-18 and cTnI and the expression levels of the miR-1 and miR-146b could be used to predict VMC among children and this approach may reinforce the diagnosis of VMC in clinical practices.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27997912     DOI: 10.1159/000453185

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

Review 1.  Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.

Authors:  Perry V Halushka; Andrew J Goodwin; Marc K Halushka
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

2.  Andrographolide attenuates viral myocarditis through interactions with the IL-10/STAT3 and P13K/AKT/NF-κβ signaling pathways.

Authors:  Yaxin Zhao; Meng Wang; Yang Li; Wanting Dong
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

3.  An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.

Authors:  Fei Xie; Dan Dong; Na Du; Liang Guo; Weihua Ni; Hongyan Yuan; Nannan Zhang; Jiang Jie; Guomu Liu; Guixiang Tai
Journal:  Mol Med Rep       Date:  2019-07-29       Impact factor: 2.952

Review 4.  The microRNA in ventricular remodeling: the miR-30 family.

Authors:  Xiaonan Zhang; Shaoyang Dong; Qiujin Jia; Ao Zhang; Yanyang Li; Yaping Zhu; Shichao Lv; Junping Zhang
Journal:  Biosci Rep       Date:  2019-08-02       Impact factor: 3.840

5.  Diagnostic Performance of Serum CK-MB, TNF-α and Hs-CRP in Children with Viral Myocarditis.

Authors:  Jia Chen; Yuanying Deng
Journal:  Open Life Sci       Date:  2019-03-20       Impact factor: 0.938

Review 6.  Necroptosis and Viral Myocarditis: Tumor Necrosis Factor α as a Novel Biomarker for the Diagnosis of Viral Myocarditis.

Authors:  Jin Zhou; Jing Xu; Peng Li; Shan Sun; Yimiti Kadier; Shiying Zhou; Aijuan Cheng
Journal:  Front Cell Dev Biol       Date:  2022-05-04

7.  Signs of Cardiac Injury in Critically Ill Paediatric Patients with COVID-19: a Single-Center Experience in Brazil.

Authors:  Marcelo Felipe Kozak; Yuri Caldas Pessoa; Luciana Oliveira Castro E Silva; Manuela Baima Cabral; Barbara Costalonga Pereira Leite; Juliana Duarte Diniz; Aline Saliba; Selma Harue Kawahara
Journal:  Arq Bras Cardiol       Date:  2022-05       Impact factor: 2.667

8.  Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization.

Authors:  Honghui Yang; Yan Chen; Chuanyu Gao
Journal:  Oncotarget       Date:  2017-08-10

Review 9.  The Role of Non-coding RNAs in Viral Myocarditis.

Authors:  Cong Zhang; Yan Xiong; Lijin Zeng; Zhihua Peng; Zhihao Liu; Hong Zhan; Zhen Yang
Journal:  Front Cell Infect Microbiol       Date:  2020-07-02       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.